Assyro AI

Orange Book product · Brand (NDA)

PATADAY TWICE DAILY RELIEF

OLOPATADINE HYDROCHLORIDE

Brand (NDA)NDA 020688OTC ALCON LABS INC

At a glance

Dec 18, 1996

Approved

Brand (NDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 18, 1996

    29 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

OLOPATADINE HYDROCHLORIDE

Strength

EQ 0.1% BASE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Not listed

Application

NDA 020688

Product number

001

Marketing status

OTC

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.